CEACAM5 and liver cancer: Meanwhile, we found that the CEA level in blood drawing was significantly higher (41.94 ± 139.34 vs. 7.83 ± 29.23, p = 0.013) in patients with liver cancer of HBV cirrhosis than those of non-HBV cirrhosis (Figure 1D).